SeaSpine to Host Investor Meeting on October 15, 2015 in Conjunction With the North American Spine Society (NASS) Annual Meeting

VISTA, Calif., Oct. 1, 2015 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will host a meeting for analysts and institutional investors on Thursday, October 15, 2015, in Chicago from 7:30 a.m. to approximately 9:00 a.m. Central Time. The meeting will include presentations by members of SeaSpine's senior management team highlighting the Company's business strategy and plans for executing on related growth initiatives, as well as presentations by leading spine surgeons who will provide relevant customer perspectives.

A live webcast of the event will be accessible from the Investor page of the SeaSpine corporate website at www.seaspine.com. A replay will be available on the Company's website following the event.

ABOUT SEASPINE

SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. The SeaSpine spinal fusion hardware portfolio consists of an extensive line of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. Expertise in both orthobiologic sciences and spinal fusion hardware product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products through a network of independent sales agents in the United States and through stocking distributors in over 30 countries worldwide. Read more about SeaSpine at the company's website, www.seaspine.com.

CONTACT: Investor Relations Contact: Lynn Pieper or Leigh Salvo (415) 513-1281 ir@seaspine.com

Source:SeaSpine